The 7investing Podcast

Shockwave (SWAV) Receives Buyout Offer from J&J: What Investors Should Know

04.05.2024 - By 7investingPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

ShockWave Medical (Nasdaq: SWAV), the innovative pioneer of intravascular lithotripsy, has received an all-cash acquisition offer from Johnson & Johnson (NYSE: JNJ) for $335 per share. In today's episode, 7investing advisors Luke Hallard and Simon Erickson discuss why we made ShockWave a 7investing recommendation, several financial details of the offer, and what investors should expect going forward.

---

Send in a voice message: https://podcasters.spotify.com/pod/show/7investing/message

More episodes from The 7investing Podcast